218 related articles for article (PubMed ID: 31792084)
1. Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors.
Zibetti Dal Molin G; Westin SN; Msaouel P; Gomes LM; Dickens A; Coleman RL
Int J Gynecol Cancer; 2020 Jan; 30(1):89-93. PubMed ID: 31792084
[TBL] [Abstract][Full Text] [Related]
2. A real or apparent decrease in glomerular filtration rate in patients using olaparib?
Bruin MAC; Korse CM; van Wijnen B; de Jong VMT; Linn SC; van Triest B; Rosing H; Beijnen JH; van den Broek D; Huitema ADR
Eur J Clin Pharmacol; 2021 Feb; 77(2):179-188. PubMed ID: 33319340
[TBL] [Abstract][Full Text] [Related]
3. Chromium-51 ethylenediamine tetraacetic acid glomerular filtration rate: a better predictor than glomerular filtration rate calculated by the Cockcroft-Gault formula for renal involvement in systemic lupus erythematosus patients.
Godfrey T; Cuadrado MJ; Fofi C; Abbs I; Khamashta MA; Nunan T; Hughes GR
Rheumatology (Oxford); 2001 Mar; 40(3):324-8. PubMed ID: 11285381
[TBL] [Abstract][Full Text] [Related]
4. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old.
Van Den Noortgate NJ; Janssens WH; Delanghe JR; Afschrift MB; Lameire NH
J Am Geriatr Soc; 2002 Jul; 50(7):1278-82. PubMed ID: 12133025
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of six radionuclidic and non-radionuclidic methods for the assessment of glomerular filtration rate in patients with chronic renal failure].
Fotopoulos A; Bokharhli JA; Tsiouris S; Katsaraki A; Papadopoulos A; Tsironi M; Theodorou J
Hell J Nucl Med; 2006; 9(2):133-40. PubMed ID: 16894423
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.
Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M
Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752
[TBL] [Abstract][Full Text] [Related]
7. Assessment of renal function before contrast media injection: right decisions based on inaccurate estimates.
Ptáčník V; Zogala D; Skibová D; Jiskrová H; Trnka J; Tesař V; Ryšavá R; Šámal M
Eur Radiol; 2019 Jun; 29(6):3192-3199. PubMed ID: 30413953
[TBL] [Abstract][Full Text] [Related]
8. Compare serum creatinine versus Renal
Rabadi MH; Aston CE
J Spinal Cord Med; 2016 Nov; 39(6):638-644. PubMed ID: 26190465
[TBL] [Abstract][Full Text] [Related]
9. Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Clin Nephrol; 2008 Jul; 70(1):10-7. PubMed ID: 18793543
[TBL] [Abstract][Full Text] [Related]
10. How safe is rucaparib in ovarian cancer?
Cosgrove CM; O'Malley DM
Expert Opin Drug Saf; 2018 Dec; 17(12):1249-1255. PubMed ID: 30449210
[No Abstract] [Full Text] [Related]
11. A new quantitative method for estimating glomerular filtration rate and its clinical value.
Cheng MH; Zeng FW; Xie LJ; Li JF; Zhang F; Jiang H
Clin Physiol Funct Imaging; 2016 Mar; 36(2):118-25. PubMed ID: 25412856
[TBL] [Abstract][Full Text] [Related]
12. Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment.
Kingdon EJ; Knight CJ; Dustan K; Irwin AG; Thomas M; Powis SH; Burns A; Hilson AJ; Black CM
Rheumatology (Oxford); 2003 Jan; 42(1):26-33. PubMed ID: 12509609
[TBL] [Abstract][Full Text] [Related]
13. [Obesity as a risk factor of chronic kidney disease in patients undergoing primary angioplasty].
Bachórzewska-Gajewska H; Małyszko J; Małyszko J; Poniatowski B; Musiał W; Dobrzycki S; Kinalska I
Pol Arch Med Wewn; 2006 Oct; 116(4):916-23. PubMed ID: 18416292
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Renal Clearance in Patients With Hemorrhagic Stroke.
Morbitzer KA; Jordan JD; Dehne KA; Durr EA; Olm-Shipman CM; Rhoney DH
Crit Care Med; 2019 Jun; 47(6):800-808. PubMed ID: 30870191
[TBL] [Abstract][Full Text] [Related]
15. GFR in Patients with β-Thalassemia Major.
Milo G; Feige Gross Nevo R; Pazgal I; Gafter-Gvili A; Shpilberg O; Gafter U; Erman A; Stark P
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1350-6. PubMed ID: 25964308
[TBL] [Abstract][Full Text] [Related]
16. Cimetidine improves prediction of the glomerular filtration rate by the Cockcroft-Gault formula in renal transplant recipients.
Kemperman FA; Surachno J; Krediet RT; Arisz L
Transplantation; 2002 Mar; 73(5):770-4. PubMed ID: 11907426
[TBL] [Abstract][Full Text] [Related]
17. Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment.
Schück O; Teplan V; Sibová J; Stollová M
Int J Clin Pharmacol Ther; 2004 Feb; 42(2):93-7. PubMed ID: 15180169
[TBL] [Abstract][Full Text] [Related]
18. A comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) in cancer patients.
Poole SG; Dooley MJ; Rischin D
Ann Oncol; 2002 Jun; 13(6):949-55. PubMed ID: 12123341
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of population with normal serum creatinine impaired renal function and: the validation of a MDRD formula in a healthy general population.
Kang YS; Han KH; Han SY; Kim HK; Cha DR
Clin Nephrol; 2005 Apr; 63(4):258-66. PubMed ID: 15847252
[TBL] [Abstract][Full Text] [Related]
20. Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors.
Gupta S; Hanna PE; Ouyang T; Yamada KS; Sawtell R; Wang Q; Katz-Agranov N; Feghali L; Krasner CN; Bouberhan S; Castro CM; Sise ME
J Natl Cancer Inst; 2023 Jul; 115(7):831-837. PubMed ID: 37074956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
